Literature DB >> 31556926

Antibody Drug Conjugates for Cancer Treatment.

Christine M Walko1, Howard Jack West2.   

Abstract

Year:  2019        PMID： 31556926     DOI： 10.1001/jamaoncol.2019.3552

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Antibody-Drug Conjugate Efficacy in Neuroblastoma: Role of Payload, Resistance Mechanisms, Target Density, and Antibody Internalization.

Authors:  Samantha Buongervino; Maria V Lane; Emily Garrigan; Doncho V Zhelev; Dimiter S Dimitrov; Kristopher R Bosse
Journal:  Mol Cancer Ther       Date:  2021-08-31       Impact factor: 6.261

2.  Assessments of the In Vitro and In Vivo Linker Stability and Catabolic Fate for the Ortho Hydroxy-Protected Aryl Sulfate Linker by Immuno-Affinity Capture Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometric Assay.

Authors:  Byeong Ill Lee; Seo-Jin Park; Yuri Park; Seok-Ho Shin; Jang-Mi Choi; Min-Jae Park; Jeong-Hyeon Lim; Sun Young Kim; Hyangsook Lee; Young G Shin
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

Review 3.  Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review.

Authors:  Suhail Ahmad Mir; Laraibah Hamid; Ghulam Nabi Bader; Ambreen Shoaib; Mohamed Rahamathulla; Mohammad Y Alshahrani; Prawez Alam; Faiyaz Shakeel
Journal:  Molecules       Date:  2022-10-05       Impact factor: 4.927

Review 4.  Biotechnology Applications of Cell-Free Expression Systems.

Authors:  August Brookwell; Javin P Oza; Filippo Caschera
Journal:  Life (Basel)       Date:  2021-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.